SNAPI is an intelligence service that describes the current status of the Chinese API industry.

In the currently expanding Chinese chemical manufacturing environment, many companies claim to make and supply just about everything, which is just not true from a commercial and supply reliability viewpoint.
SNAPI provides information about currently regulated and approved Chinese suppliers of pharmaceutical APIs.
SNAPI's team of consultants has created the world's first properly researched guide to the Chinese API sector.

Work on SNAPI was started in January 2006 by a team of consultants originated by Brychem Business Consulting, an internationally acknowleged global fine chemical consultancy, in partnership with WiCON International, the publisher of Pharma China. It has been developed using a team of global API industry experts which continuously carries out independently-originated customer surveys.

SNAPI is a real-time intelligence service:
SNAPI's research group continually validates and updates the SNAPI databases, thus ensuring that our clients always have access to the most recent and updated information. Information is continuously collected and updated (MONTHLY UPDATES) using field and desk research, which includes site visits, trade shows and telecommunications contacts with producers, traders and buyers.

SNAPI features include:

• Online access: databases updated monthly.
• Contains hundreds of carefully produced company profiles and contact information
• Lists thousands of APIs and intermediates and which companies make them
• Shows company regulatory compliance, with DMFs, COSs and other certifications
  
  
• Search by API or by intermediate (common name or CAS number)
• Search by regulatory certifications, (EU COSs, US DMFs, SFDA GMPs etc.)
• Search by company name, province in China
  
• Display / print off (or cut and paste) comprehensive company profiles



• Alternatively, if you have MSAccess 2000 (or higher) installed on your PC, a desktop version can be supplied
  (no monthly updates). Please enquire if you would like to use this option.